HIV/AIDS
Research from the United States in HIV/AIDS provides new insights
Published in AIDS Weekly, October 9th, 2006
Study 1: A locally elicited immune response at mucosal entry sites will be insufficient to limit simian immunodeficiency virus replication and dissemination in infants.
According to recent research from the United States, "A vaccine to protect human immunodeficiency virus (HIV)-exposed infants is an important goal in the global fight against the HIV pandemic.
"Two major challenges in pediatric HIV vaccine design are the competence of the neonatal/infant immune system in comparison to the adult immune system and the frequent exposure to HIV via...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-10-09)
More Articles from AIDS Weekly
- HIV/AIDS Epidemiology
HIV drug-resistant and nonsubtype B strains increasingly common in perinatally infected - HIV/AIDS Pathogenesis
Protection against X4-tropic HIV-1 superinfection involves CD4 HIV-1 Nef mechanisms - HIV/AIDS Prognostics
Time from HIV-1 seroconversion to CD4/CD8 ratio inversion predicts time to AIDS - HIV/AIDS Therapy
Interleukin-2 reconstitutes defective HIV- and CMV-specific CD8+ cell proliferation in HIV/AIDS - HIV/AIDS Transmission
Breastfeeding plus zidovudine reduces mortality rate at 7 months compared with formula feeding - Antifungals
Combination antifungal therapy valuable in pre-emptive management of high-risk patients - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
